Catalyst Pharmaceuticals Inc (CPRX) — Net Asset Quality Index
Catalyst Pharmaceuticals Inc (CPRX) has a Net Asset Quality Index of 86.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.11 Billion minus total liabilities of $152.54 Million yields net assets of $954.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Catalyst Pharmaceuticals Inc (CPRX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Catalyst Pharmaceuticals Inc Net Asset Quality Index Over Time (2002–2025)
This chart shows how Catalyst Pharmaceuticals Inc's Net Asset Quality Index has evolved across 23 annual periods from 2002 to 2025. As of December 2025, the index stands at 86.2%, representing net assets of $954.27 Million against total assets of $1.11 Billion USD. See Catalyst Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Catalyst Pharmaceuticals Inc (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Catalyst Pharmaceuticals Inc from 2002 to 2025, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Catalyst Pharmaceuticals Inc (CPRX) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.2% | $954.27 Million | $1.11 Billion | $152.54 Million | ▲ +0.8 pp |
| 2024 | 85.5% | $727.63 Million | $851.41 Million | $123.78 Million | ▲ +3.0 pp |
| 2023 | 82.5% | $387.88 Million | $470.11 Million | $82.23 Million | ▲ +2.5 pp |
| 2022 | 80.0% | $300.42 Million | $375.63 Million | $75.21 Million | ▼ -7.0 pp |
| 2021 | 87.0% | $206.83 Million | $237.79 Million | $30.96 Million | ▼ -1.2 pp |
| 2020 | 88.2% | $169.60 Million | $192.35 Million | $22.76 Million | ▲ +10.2 pp |
| 2019 | 78.0% | $87.63 Million | $112.38 Million | $24.75 Million | ▼ -6.0 pp |
| 2018 | 84.0% | $50.78 Million | $60.45 Million | $9.67 Million | ▼ -10.8 pp |
| 2017 | 94.8% | $80.96 Million | $85.39 Million | $4.42 Million | ▲ +0.6 pp |
| 2016 | 94.3% | $39.31 Million | $41.71 Million | $2.40 Million | ▲ +1.9 pp |
| 2015 | 92.3% | $55.48 Million | $60.10 Million | $4.63 Million | ▲ +12.0 pp |
| 2014 | 80.3% | $35.24 Million | $43.91 Million | $8.67 Million | ▼ -4.1 pp |
| 2013 | 84.3% | $21.39 Million | $25.37 Million | $3.98 Million | ▼ -2.8 pp |
| 2012 | 87.1% | $14.62 Million | $16.79 Million | $2.17 Million | ▲ +26.9 pp |
| 2011 | 60.2% | $3.76 Million | $6.25 Million | $2.49 Million | ▼ -34.4 pp |
| 2010 | 94.6% | $5.52 Million | $5.83 Million | $313.71K | ▼ -1.0 pp |
| 2009 | 95.6% | $7.62 Million | $7.97 Million | $348.52K | ▲ +7.9 pp |
| 2008 | 87.8% | $10.56 Million | $12.03 Million | $1.47 Million | ▼ -10.1 pp |
| 2007 | 97.9% | $16.32 Million | $16.68 Million | $357.17K | ▲ +1.6 pp |
| 2006 | 96.3% | $19.85 Million | $20.62 Million | $772.85K | ▲ +39.7 pp |
| 2005 | 56.6% | $446.46K | $789.45K | $342.99K | ▼ -6.9 pp |
| 2004 | 63.4% | $117.58K | $185.38K | $67.80K | ▲ +23.2 pp |
| 2002 | 40.2% | $44.89K | $111.59K | $66.70K | — |